Christopher C. Schreiber
DirectorMr. Christopher C. Schreiber, also known as Chris, is Director at Q/C Technologies, Inc. (formerly known as TNF Pharmaceuticals, Inc.) (formerly known as MyMD Pharmaceuticals, Inc.) since August 08, 2017 and served as its President until April 16, 2021. He served as Executive Chairman of the Board at Q/C Technologies, Inc. (formerly known as TNF Pharmaceuticals, Inc.) (formerly known as MyMD Pharmaceuticals, Inc.) until November 20, 2020 and served as its Chief Executive Officer since November 20, 2020 until April 16, 2021. Mr. Schreiber joined Paulson Investment Company, Inc., in August 2002 as Manager of Paulson Capital (Delaware) Corp.?s Manhattan branch office. In July 2005, he was promoted to Senior Vice President of National Sales. Prior to joining Paulson Investment Company, Inc., he was employed by Weatherly Securities. He is a Member of the National Investment Banking Association and is on the Board of Advisors for Blue Jays Unlimited, which is a Board at Johns Hopkins University that supports student athletes. He has experience in the securities industry. As the Managing Director of Capital Markets at Taglich Brothers, Inc., he builds upon his extensive background in capital markets, deal structures and syndications. He served as director of Paulson Investment Company and serves as Director and partner of Long Island Express North, an elite lacrosse training organization for teams and individuals. He also volunteers on the board of directors for Fox Lane Youth Lacrosse, a community youth program. He earned a Bachelor?s degree in Political Science from Johns Hopkins University.
Positions
- Company NameQ/C Technologies, Inc.Stock CodeQCLSPositionDirectorColleagues
- JNJoshua N. SilvermanExecutive Chairman of the Board
- ITIan Thomas RhodesChief Financial Officer
- MGMitchell GlassChief Medical Officer & Director
- YEYossef EhrlichmanChief Technology Officer
- RSRobert SchatzInvestor Relations Officer
- BJBilly Joe WhiteIndependent Director
- SAStephen A. FrisciaIndependent Director
